Erratum: Memantine (Ebixa) for dementia in moderately severe Alzheimer’s disease

Published 2008-12-01 00:00:00

Information on the dose titration of memantine contained in Table 1 of the August 2008 NPS RADAR review of memantine was incorrect. The dose for the tablet formulation was correct but the dose for the oral solution was mistakenly halved.

The error has been rectified on the NPS website and all electronic copies of the review now show the correct dose (Table 1). We apologise for any confusion.

Table 1: Initial dose titration

Week

Dose

Week 1

Morning: half a tablet or 10 drops of solution

Week 2

Morning: half a tablet or 10 drops of solution

Evening: half a tablet or 10 drops of solution

Week 3

Morning: 1 tablet or 20 drops of solution

Evening: half a tablet or 10 drops of solution

Week 4

Morning: 1 tablet or 20 drops of solution

Evening: 1 tablet or 20 drops of solution

 

RSS FeedRSS feed

Date published: 2008-12-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.